Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer.

Autor: Ladjevardi CO; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden., Skribek M; Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, 171 76, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden., Koliadi A; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden., Rydén V; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden., El-Naggar AI; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Digkas E; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Mälarsjukhuset, 633 49, Eskilstuna, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. antonios.valachis@oru.se., Ullenhag GJ; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Nov 07; Vol. 74 (1), pp. 14. Date of Electronic Publication: 2024 Nov 07.

Combination treatment with ornidazole and dacarbazine inhibits proliferation, cell migration and induces DNA damage in melanoma cells.

Autor: Evyapan, Gulsah¹, Luleyap, H. Umit² umitluleyap@gmail.com, Comertpay, Gamze², Aksoy, Gulsevinc², Kaplan, H. Mahir³, Oksuz, Hale², Yilmaz, M. Bertan², Pazarci, Percin²

Publikováno v: Indian Journal of Experimental Biology. Sep2024, Vol. 62 Issue 9, p722-729. 8p.